New Faculty

Jude Phillip, PhD Jude Phillip is an INBT core faculty member and assistant professor in the Biomedical Engineering Department. He received his undergraduate degree in chemical engineering from the City College of New York, his PhD in chemical and biomolecular engineering from Hopkins, and completed his postdoctoral work at Weil Cornell Medicine. Phillip researches biological aging dynamics in the context of health and disease. He combines engineering approaches with translational aging and oncology research to develop strategies and technologies to probe aging and identify mechanisms to modify ageing trajectories to drive healthy aging.

Deok-Ho Kim, PhD Deok-Ho Kim is an INBT associate faculty member with joint appointments in the Biomedical Engineering Department and Johns Hopkins School of Medicine. He has a bachelor’s degree in mechanical engineering from Pohang University of Science and Technology, a master’s degree in mechanical and aerospace engineering from Seoul National University, and a PhD in biomedical engineering from Hopkins. His research leverages recent advances in human pluripotent stem cell biology, tissue engineering, and microfabrication to better understand complex cellular behavior in response to microenvironmental cues in normal, aging, and disease states.

Sashank Reddy, MD, PhD Sashank Reddy is an INBT associate faculty member and assistant professor of Plastic and Reconstructive Surgery at the Johns Hopkins School of Medicine. He is also the Medical Director of Johns Hopkins Technology Ventures and an accomplished entrepreneur and biomedical innovator. He received his undergraduate degree from Hopkins and completed his MD and PhD at Harvard Medical School. Reddy’s current research centers on mechanisms of regeneration and homeostasis in skin and development of nanomaterials to support tissue regeneration and cell delivery.

In 2021, Sangmoo Jeong will join the INBT as a core faculty member and assistant professor in the Chemical and Biomolecular Engineering Department. Jeong’s lab will focus on developing technologies to deepen the understanding of the interplay between metabolic dysfunctions and disease initiation and progression.